Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women

Cancer Genomics and Proteomics

Volumn 9, Issue 1, 2012, Pages 27-35

  Izbicka, Elzbieta ^a   Streeper, Robert T ^a   Michalek, Joel E ^b   Louden, Christopher L ^b   Diaz III, Armando ^a   Campos, David R ^a  

^a Cancer Prevention and Cure Ltd   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Asthma; Autoantibodies; Biomarker; Multiplex assay; Non small cell lung cancer; Plasma

Indexed keywords

ADIPONECTIN; AMYLIN; AMYLOID A PROTEIN; AMYLOID P COMPONENT; BIOLOGICAL MARKER; C PEPTIDE; C REACTIVE PROTEIN; CD40 LIGAND; EPIDERMAL GROWTH FACTOR; FAS ANTIGEN; GAMMA INTERFERON; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; ASTHMA; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENDER; HUMAN; IMMUNOASSAY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PLASMA; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE;

EID: 84855381299     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/ cancer-facts-figures-2011. Accessed October 8, 2011.
2. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
3. The National Lung Screening Trial Research: Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395-409, 2011.
4. Infante M, Chiesa G, Solomon D, Morenghi E, Passera E, Lutman FR, Bottoni E, Cariboni U, Errico V, Voulaz E, Ferraroli G, Testori A, Inzirillo F, Chiarenza M, Roncalli M, Cavuto S, Chiti A, Alloisio M and Ravasi G: Surgical procedures in the DANTE trial, a randomized study of lung cancer early detection with spiral computed tomography: comparative analysis in the screening and control arm. J Thorac Oncol 6: 327-335, 2011.
5. Brenner DJ and Hall EJ: Computed tomography - an increasing source of radiation exposure. N Engl J Med 357: 2277-2284, 2007. (Pubitemid 350190758)
6. Oxnard GR, Zhao B, Sima CS, Ginsberg MS, James LP, Lefkowitz RA, Guo P, Kris MG, Schwartz LH and Riely GJ: Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes. J Clin Oncol 29: 3114-3119, 2011.
7. Santillan AA, Camargo CA Jr. and Colditz GA: A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 14: 327-334, 2003. (Pubitemid 36735101)
8. Doria-Rose V and Szabo E: Screening and prevention of lung cancer. In: Kernstine K and Reckamp K (editors). Lung Cancer: A Multidisciplinary Approach to Diagnosis and Management. New York. Demos Medical Publishing, pp. 53-72, 2010.
9. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabro E, Croce CM, Pastorino U and Sozzi G: MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 108: 3713-3718, 2011.
10. Service RF: Proteomics. Proteomics ponders prime time. Science 321(5897): 1758-1761, 2008.
11. Farlow EC, Patel K, Basu S, Lee BS, Kim AW, Coon JS, Faber LP, Bonomi P, Liptay MJ and Borgia JA: Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res 16: 3452-3462, 2010.
12. Gogali A, Charalabopoulos K, Zampira I, Konstantinidis AK, Tachmazoglou F, Daskalopoulos G, Constantopoulos SH and Dalavanga Y: Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers. Chest 138: 1173-1179, 2010.
13. Yang Y, Zhao S, Fan Y, Zhao F, Liu Q, Hu W, Liu D, Fan K and Wang J: Detection and identification of potential biomarkers of non-small cell lung cancer. Technol Cancer Res Treat 8: 455-466, 2009.
14. Patz EF Jr., Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE, 2nd: Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 25: 5578-5583, 2007.
15. Streeper R, Izbicka E, Baek S, Inventors; Method of Identifying Biomarkers in Human Serum Indicative of Pathologies Of Human Lung Tissues. United States Patent 7,888,051, 2011.
16. Izbicka E, Campos D, Carrizales G and Patnaik A: Biomarkers of anticancer activity of R115777 (Tipifarnib, Zarnestra) in human breast cancer models in vitro. Anticancer Res 25: 3215-3223, 2005. (Pubitemid 41105192)
17. Vapnik V: Statistical Learning Theory. New York; Wiley 1998.
18. Han J and Kamber M: Data Mining, Concepts and Techniques. 2nd ed. Amsterdam: Elsevier, 2006.
19. www.r-project.org
20. Lee M: Using support vector machine with a hybrid feature selection method to the stock trend prediction. Expert Systems Applications 36: 10896-10904, 2009.
21. Mok TS, Zhou Q, Leung L and Loong HH: Personalized medicine for non-small cell lung cancer. Expert Rev Anticancer Ther 10: 1601-1611, 2010.
22. Gonzalez G, Crombet T and Lage A: Chronic vaccination with a therapeutic EGF-based cancer vaccine: a review of patients receiving long lasting treatment. Curr Cancer Drug Targets 11: 103-110, 2011.
23. Grootenboer N, Bosch JL, Hendriks JM and van Sambeek MR: Epidemiology, aetiology, risk of rupture and treatment of abdominal aortic aneurysms: does sex matter? Eur J Vasc Endovasc Surg 38: 278-284, 2009.
24. Mattsson C and Olsson T: Estrogens and glucocorticoid hormones in adipose tissue metabolism. Curr Med Chem 14: 2918-2924, 2007. (Pubitemid 350201658)
25. Gandolfo MT, Verzola D, Salvatore F, Gianiorio G, Procopio V, Romagnoli A, Giannoni M and Garibotto G: Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol 56: 1-14, 2004. (Pubitemid 38937536)
26. Ng MK, Quinn CM, McCrohon JA, Nakhla S, Jessup W, Handelsman DJ, Celermajer DS and Death AK: Androgens up-regulate atherosclerosis-related genes in macrophages from males but not females: molecular insights into gender differences in atherosclerosis. J Am Coll Cardiol 42: 1306-1313, 2003. (Pubitemid 37188360)
27. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA and Lusis AJ: Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 16: 995-1004, 2006. (Pubitemid 44162259)
28. Whitacre CC, Reingold SC and O'Looney PA: A gender gap in autoimmunity. Science. 283: 1277-1278, 1999. (Pubitemid 129507205)
29. Crockett ET, Spielman W, Dowlatshahi S and He J: Sex differences in inflammatory cytokine production in hepatic ischemia-reperfusion. J Inflamm (Lond). 3: 16, 2006.
30. Wirtz PH, von Kanel R, Rohleder N and Fischer JE: Monocyte proinflammatory cytokine release is higher and glucocorticoid sensitivity is lower in middle aged men than in women independent of cardiovascular risk factors. Heart. 90: 853-858, 2004. (Pubitemid 39005925)
31. Planchard D, Loriot Y, Goubar A, Commo F and Soria JC: Differential expression of biomarkers in men and women. Semin Oncol 36: 553-565, 2009.
32. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z and Zhu L: Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 51: 102-112, 2005. (Pubitemid 40024018)
33. Lau SK, Boutros PC, Pintilie M, Blackhall FH, Zhu CQ, Strumpf D, Johnston MR, Darling G, Keshavjee S, Waddell TK, Liu N, Lau D, Penn LZ, Shepherd FA, Jurisica I, Der SD and Tsao MS: Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol 25: 5562-5569, 2007.
34. Jones NA, Leport M, Holand T, Vos T, Morgan M, Fink M, Pruniaux MP, Berthelier C, O'Connor BJ, Bertrand C and Page CP: Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD. Pulm Pharmacol Ther 20: 60-68, 2007. (Pubitemid 44755041)
35. Wagner B, Jakobs S, Habermeyer M, Hippe F, Cho-Chung YS, Eisenbrand G and Marko D: 7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine, a potent inhibitor of cAMP-specific phosphodiesterase, enhancing nuclear protein binding to the CRE consensus sequence in human tumour cells. Biochem Pharmacol 63: 659-668, 2002. (Pubitemid 34460687)
36. Shi M, Zheng Y, Garcia A, Xu L and Foster DA: Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras. Cancer Lett 258: 268-275, 2007. (Pubitemid 350101020)
37. Vercelli D: Arginase: marker, effector, or candidate gene for asthma? J Clin Invest 111: 1815-1817, 2003.
38. Rotondo R, Mastracci L, Piazza T, Barisione G, Fabbi M, Cassanello M, Costa R, Morandi B, Astigiano S, Cesario A, Sormani MP, Ferlazzo G, Grossi F, Ratto GB, Ferrini S and Frumento G: Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression. Int J Cancer 123: 1108-1116, 2008.
39. Diamandis EP: Cancer biomarkers: Can we turn recent failures into success? J Natl Cancer Inst 102: 1462-1467, 2010.